首页 | 本学科首页   官方微博 | 高级检索  
检索        


Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Authors:Minoko Takanashi  Eileen Selogie  Jo‐Anna Reems  David Stroncek  Magali J Fontaine  John Girdlestone  Henk S P Garritsen  Pampee Young  David H McKenna  Zbigniew M Szczepiorkowski  for the Biomedical Excellence for Safer Transfusion Collaborative
Institution:1. Japanese Red Cross Society Blood Service Headquarters, Tokyo, Japan;2. Biomedical Excellence for Safer Transfusion (BEST) Collaborative, Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire;3. University of Utah, Salt Lake City, Utah;4. Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland;5. Transfusion Services, Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland;6. Stem Cells and Immunotherapies, NHS Blood and Transplant, The John Radcliffe Hospital, Oxford, UK;7. Institute for Clinical Transfusion MedicineMunicipal Hospital Braunschweig gGmbH;8. Fraunhofer Institute for Surface Engineering and Thin Film IST, Braunschweig, Germany;9. Vanderbilt University, Nashville, Tennessee;10. Molecular & Cellular Therapeutics, University of Minnesota, Saint Paul, Minnesota;11. Dartmouth‐Hitchcock Medical Center, Lebanon, New Hampshire;12. Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号